Idiopathic Triglyceride Deposit Cardiomyovasculopathy Clinical Trial
Official title:
Phase I/IIa Study of CNT-01 in Patients With Idiopathic Triglyceride Deposit
The purpose of this study is to assess the safety and to examine the index of the efficacy after repeated dosing of CNT-01 in patients with idiopathic triglyceride deposit cardiomyovasculopathy.
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment